Brevipil 75mg Tablet
Marketer
Sun Pharmaceutical Industries Ltd
Salt Composition
Brivaracetam (75mg)
Overview Brevipil 75mg Tablet
Epileptic seizures are managed with the anticonvulsant medication, Brevipil 75mg tablets. This medication can be administered independently or in conjunction with other therapies to control seizures. Continued use is crucial for sustained seizure prevention. Brevipil 75mg tablets work by reducing abnormal brain electrical activity. Daily consumption, with or without food, is recommended at the same time each day for optimal effectiveness. Dosage frequency is determined individually by your physician to effectively manage seizures and may be gradually adjusted. It’s generally prescribed for long-term use; continuation as directed by your doctor is vital, even if you feel well, as discontinuation or missed doses may exacerbate seizures. Never cease treatment without consulting your physician, as abrupt cessation can worsen seizures. Common side effects include dizziness, headache, nausea, and vomiting. Behavioral changes, aggression, irritability, and agitation can also occur. These side effects are more prevalent initially and usually diminish with continued use. While many side effects are mild, some may be serious. Suicidal ideation has been reported in a small percentage of patients. Report any significant mood changes to your doctor promptly. Before commencing treatment, inform your physician of any pre-existing liver or kidney disease, depression, suicidal thoughts, or pregnancy (or pregnancy plans). Nursing mothers require medical consultation prior to use.
Uses of Brevipil 75mg Tablet
Convulsive disorders
Major Benefits of Brevipil 75mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 75mg Brevipil tablet whole; avoid chewing, crushing, or breaking it. While it can be taken with or without food, consistent timing is recommended.
Common Side effects of Brevipil 75mg Tablet:
- Behavioral changes
- Agitation
- Aggressive behavior
- Dizziness
- Sedation
- Drowsiness
- Neuropsychiatric symptoms
How to use Brevipil 75mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Brevipil 75mg Tablets can be administered with or without food, although consistent timing is recommended.
How Brevipil 75mg Tablet works:
Epilepsy treatment, Brevipil 75mg tablets, targets nerve cell receptors (SV2A). By binding to these sites, it reduces excessive neuronal firing, thereby preventing the propagation of seizure-inducing electrical impulses within the brain.
SAFETY ADVICE
AlcoholUNSAFE
Combining Brevipil 75mg Tablet with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Brevipil 75mg tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
Data on Brevipil 75mg Tablet use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Taking a Brevipil 75mg tablet might reduce alertness, impair vision, and cause drowsiness or dizziness. Refrain from driving if you experience these effects.
KidneySAFE IF PRESCRIBED
Brevipil 75mg tablets are considered safe for individuals with kidney impairment; no dosage modification is advised. However, its use is contraindicated in end-stage renal disease given the absence of supporting clinical trial data.
LiverCAUTION
Individuals with hepatic impairment should exercise prudence when using Brevipil 75mg tablets. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Brevipil 75mg Tablet :
NA
Facts to Know About Brevipil 75mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Levetiracetam Analog |
| Developing Habits | No. |
| Type of Treatment | Neuroscience (Central Nervous System) |
| Actions | AED: A protein ligand bound to synaptic vesicle 2 |


